These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 9862786

  • 1. Levosimendan, a calcium sensitizer in cardiac muscle, induces relaxation in coronary smooth muscle through calcium desensitization.
    Bowman P, Haikala H, Paul RJ.
    J Pharmacol Exp Ther; 1999 Jan; 288(1):316-25. PubMed ID: 9862786
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evoked changes in cardiovascular function in rats by infusion of levosimendan, OR-1896 [(R)-N-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)acetamide], OR-1855 [(R)-6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one], dobutamine, and milrinone: comparative effects on peripheral resistance, cardiac output, dP/dt, pulse rate, and blood pressure.
    Segreti JA, Marsh KC, Polakowski JS, Fryer RM.
    J Pharmacol Exp Ther; 2008 Apr; 325(1):331-40. PubMed ID: 18171907
    [Abstract] [Full Text] [Related]

  • 5. The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan.
    Haikala H, Kaheinen P, Levijoki J, Lindén IB.
    Cardiovasc Res; 1997 Jun; 34(3):536-46. PubMed ID: 9231037
    [Abstract] [Full Text] [Related]

  • 6. Force-frequency relationship in intact mammalian ventricular myocardium: physiological and pathophysiological relevance.
    Endoh M.
    Eur J Pharmacol; 2004 Oct 01; 500(1-3):73-86. PubMed ID: 15464022
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The novel calcium sensitizer levosimendan activates the ATP-sensitive K+ channel in rat ventricular cells.
    Yokoshiki H, Katsube Y, Sunagawa M, Sperelakis N.
    J Pharmacol Exp Ther; 1997 Oct 01; 283(1):375-83. PubMed ID: 9336346
    [Abstract] [Full Text] [Related]

  • 9. Effects of calcium sensitizers on intracellular calcium handling and myocardial energetics.
    Hasenfuss G, Pieske B, Kretschmann B, Holubarsch C, Alpert NR, Just H.
    J Cardiovasc Pharmacol; 1995 Oct 01; 26 Suppl 1():S45-51. PubMed ID: 8907130
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Potassium channels in the vasodilating action of levosimendan on the human umbilical artery.
    Yildiz O, Nacitarhan C, Seyrek M.
    J Soc Gynecol Investig; 2006 May 01; 13(4):312-5. PubMed ID: 16697949
    [Abstract] [Full Text] [Related]

  • 13. Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation.
    Haikala H, Nissinen E, Etemadzadeh E, Levijoki J, Lindén IB.
    J Cardiovasc Pharmacol; 1995 May 01; 25(5):794-801. PubMed ID: 7630157
    [Abstract] [Full Text] [Related]

  • 14. Levosimendan, a new inotropic and vasodilator agent.
    Toller WG, Stranz C.
    Anesthesiology; 2006 Mar 01; 104(3):556-69. PubMed ID: 16508404
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The vasodilatory effects of levosimendan on the human internal mammary artery.
    Montes FR, Echeverri D, Buitrago L, Ramírez I, Giraldo JC, Maldonado JD, Umaña JP.
    Anesth Analg; 2006 Nov 01; 103(5):1094-8. PubMed ID: 17056938
    [Abstract] [Full Text] [Related]

  • 17. Milrinone and levosimendan during porcine myocardial ischemia -- no effects on calcium overload and metabolism.
    Axelsson B, Johansson G, Abrahamsson P, Gupta A, Tydén H, Wouters P, Haney M.
    Acta Anaesthesiol Scand; 2013 Jul 01; 57(6):719-28. PubMed ID: 23517167
    [Abstract] [Full Text] [Related]

  • 18. Functional role of potassium channels in the vasodilating mechanism of levosimendan in porcine isolated coronary artery.
    Pataricza J, Krassói I, Höhn J, Kun A, Papp JG.
    Cardiovasc Drugs Ther; 2003 Mar 01; 17(2):115-21. PubMed ID: 12975592
    [Abstract] [Full Text] [Related]

  • 19. The effects of levosimendan on myocardial function in ropivacaine toxicity in isolated guinea pig heart preparations.
    Stehr SN, Christ T, Rasche B, Rasche S, Wettwer E, Deussen A, Ravens U, Koch T, Hübler M.
    Anesth Analg; 2007 Sep 01; 105(3):641-7. PubMed ID: 17717217
    [Abstract] [Full Text] [Related]

  • 20. Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs.
    Banfor PN, Preusser LC, Campbell TJ, Marsh KC, Polakowski JS, Reinhart GA, Cox BF, Fryer RM.
    Am J Physiol Heart Circ Physiol; 2008 Jan 01; 294(1):H238-48. PubMed ID: 17982006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.